Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Fruchtman

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Mount Sinai Journal of Medicine, New York|May 24, 2003
Stem cell transplantationSteven Fruchtman
British Journal of Haematology|October 31, 2002
Exploring polycythaemia vera with fluorescence in situ hybridization: additional cryptic 9p is the most frequent abnormality detectedVesna Najfeld, Lya Montella, Angela Scalise, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 19, 2003
Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantationCelia Grosskreutz, Virginia Ross, Eileen Scigliano, et al.
Experimental Hematology|February 20, 2003
Fluorescence in situ hybridization analysis of the PRV-1 gene in polycythemia vera: implications for its role in diagnosis and pathogenesisVesna Najfeld, Shai Fuchs, Paul Merando, et al.
Experimental Hematology|September 4, 2004
Evidence for megakaryocyte engraftment following reduced-intensity conditioningDeborah L French, Steven Fruchtman, W Beau Mitchell, et al.
British Journal of Haematology|March 29, 2002
Syngeneic stem cell transplant for spent-phase polycythaemia vera: eradication of myelofibrosis and restoration of normal haematopoiesisShambavi Richard, Luis Isola, Eileen Scigliano, et al.
Leukemia Research|October 11, 2011
Treatment of polycythemia vera with imatinib mesylateRichard T Silver, Michael H Bourla, Katherine Vandris, et al.
The Oncologist|March 12, 2017
The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom First-Line Hypomethylating Agents FailChristopher R Cogle, Sandra E Kurtin, Tanya G K Bentley, et al.
Blood|January 27, 2005
Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasiaDamiano Rondelli, Giovanni Barosi, Andrea Bacigalupo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2010
Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617FWindy Berkofsky-Fessler, Monica Buzzai, Marianne K-H Kim, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Mount Sinai Journal of Medicine, New York|May 24, 2003
Stem cell transplantationSteven Fruchtman
British Journal of Haematology|October 31, 2002
Exploring polycythaemia vera with fluorescence in situ hybridization: additional cryptic 9p is the most frequent abnormality detectedVesna Najfeld, Lya Montella, Angela Scalise, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 19, 2003
Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantationCelia Grosskreutz, Virginia Ross, Eileen Scigliano, et al.
Experimental Hematology|February 20, 2003
Fluorescence in situ hybridization analysis of the PRV-1 gene in polycythemia vera: implications for its role in diagnosis and pathogenesisVesna Najfeld, Shai Fuchs, Paul Merando, et al.
Experimental Hematology|September 4, 2004
Evidence for megakaryocyte engraftment following reduced-intensity conditioningDeborah L French, Steven Fruchtman, W Beau Mitchell, et al.
British Journal of Haematology|March 29, 2002
Syngeneic stem cell transplant for spent-phase polycythaemia vera: eradication of myelofibrosis and restoration of normal haematopoiesisShambavi Richard, Luis Isola, Eileen Scigliano, et al.
Leukemia Research|October 11, 2011
Treatment of polycythemia vera with imatinib mesylateRichard T Silver, Michael H Bourla, Katherine Vandris, et al.
The Oncologist|March 12, 2017
The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom First-Line Hypomethylating Agents FailChristopher R Cogle, Sandra E Kurtin, Tanya G K Bentley, et al.
Blood|January 27, 2005
Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasiaDamiano Rondelli, Giovanni Barosi, Andrea Bacigalupo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2010
Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617FWindy Berkofsky-Fessler, Monica Buzzai, Marianne K-H Kim, et al.
Pageof 1